Skip to main content
. 2018 Aug 7;3(2):177–188. doi: 10.1007/s41669-018-0089-9

Fig. 4.

Fig. 4

Comparison of monthly HRU and costs 6 months before and 12 months after transition to PP3M. P values were obtained using a non-parametric bootstrap procedure with 500 replicates. *p value < 0.05. CI confidence interval, HRU healthcare resource utilization, NE not evaluable, PP3M once-every-3-months paliperidone palmitate